A critical gap exists in cancer care where cardiovascular risk factors are often ignored. As cancer treatments improve survival, patients are increasingly dying from preventable heart attacks and strokes, necessitating the specialized field of cardio-oncology.

When a study is presented at a major conference like ASCO, it gains visibility and a perception of having been vetted. This can create a "tailwind," leading subsequent journal reviewers to be less critical, as they may assume the work has already undergone rigorous scrutiny, which is often not the case for conference abstracts.

Of 7 million Americans annually who think they are having a heart attack, only a fraction are. Because the GIK therapy is extremely safe and non-toxic, it can be administered to all 3.5 million people with convincing symptoms. Treatment can be safely stopped for those not having an attack, ensuring the ~1.5 million who are get protected immediately, a strategy of 'treat broadly, then confirm'.

The medical field is so culturally ingrained with the belief that only randomized trials can prove causation that journals actively remove causal language (e.g., "X caused Y") from studies using observational data, even from rigorous natural experiments. This belief hinders the adoption of these valuable methods.

Disparities in blood pressure control are often not caused by clinicians treating patient groups differently within a practice. Instead, they arise because certain practices, which tend to serve more minority communities, have lower control rates for all their patients. The solution is to lift the performance of the entire practice.

Most doctors don't analyze raw studies. They follow clinical guidelines which function as algorithms. These are the output of a massive, underlying effort by researchers to synthesize thousands of trials into "pre-processed evidence" like systematic reviews, making evidence-based care scalable and efficient.

Recovering at home is not just more pleasant; it's often clinically safer and more effective. Patients are less likely to contract dangerous hospital-acquired infections (nosocomial infections), tend to mobilize more, and experience better overall outcomes. This reframes the "Hospital at Home" model as a medically superior option for certain patients, not just a cheaper or more convenient one.

Dr. Smith advises that every hospital patient should have a friend or family member act as a health advocate. This is crucial because many hospital procedures and decisions, such as pushing for knee replacements, may be driven more by economic incentives than pure medical necessity.

Economists developed "natural experiments" to find real-world situations that mimic randomized trials. This approach, where otherwise identical groups receive different "treatments" by chance, can establish causality from observational data. It represents a powerful but underutilized tool for medical research beyond traditional, expensive trials.